The incidence of invasive fungal disease (IFD) has increased in parallel with the expansion of the population at risk for IFD to include patients with cancer, solid organ transplant (SOT) and haematopoietic stem cell transplant (HSCT) recipients, those receiving immunosuppressive therapy, and patients with AIDS, major surgery, premature birth and advanced age. Additionally, the spectrum of path...